In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Religious Freedom Report: India rejects US report on religious freedom, know what is in it?
The US State Department has released its annual report on International Religious Freedom. The re
The Central Government has intensified preparations for the 'Har Ghar Tiranga' campaign on the 75
 Ranbir Kapoor and Rashmika Mandanna starrer Animal was one of the highest-grossing films of
Several bilateral agreements were signed on Monday during Prime Minister Narendra Modi's visit to
In the 35th match of IPL 2024, Delhi Capitals will clash with Sunrisers Hyderabad (DC vs SRH). By
Earthquake tremors have been felt once again in the capital Delhi at 4.42 pm on Wednesday. Let us
Six weeks ago, Saudi Arabia's aging King Salman named his son, Crown Prince Mohammed bin Salman,
IMEI Registration Rule: Very soon in India, there is going to be a change regarding the IMEI numb
King Kohli was left behind! After Joe Root, now Steve Smith is also ahead of Virat in Fab 4
Australia's swashbuckling batsman Steve Smith has put the team in a strong position in the second
Former US President Donald Trump's difficulties may increase. The committee probing the Capitol H
